查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
腸阻塞治療市場報告：至2030年的趨勢、預測與競爭分析
市場調查報告書
商品編碼
1356894

腸阻塞治療市場報告：至2030年的趨勢、預測與競爭分析

Intestinal Pseudo Obstruction Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

假性腸阻塞治療的趨勢與預測

預計到2030年，全球假性腸阻塞治療市場將達到 214 億美元，2024年至2030年年複合成長率為 5.1%。這個市場的主要促進因素是胃腸道疾病的盛行率不斷上升，醫療保健提供者和患者的意識不斷提高以及特定治療方法藥物創新的進步。全球假性腸阻塞治療市場前景廣闊，醫院/診所市場和門診護理中心市場蘊藏商機。

假性腸阻塞治療市場洞察

  • Lucintel 預測，在預測期內，藥物治療仍將是最大的細分市場。
  • 醫院仍將是最大的區隔，因為它們在腸阻塞的治療中發揮關鍵作用，特別是在重症病例和併發症的治療方面。
  • 由於該地區疾病意識的提高、主要參與者的存在以及醫療保健行業的擴張，北美在預測期內可能仍是最大的細分市場。

本報告回答了 11 個關鍵問題：

  • Q.1.細分市場中最有前途和高成長的機會為何？
  • Q.2.哪個細分市場將以更快的速度成長？理由為何？
  • Q.3.哪些地區未來會出現更快的成長？理由為何？
  • Q.4.影響市場動態的主要因素有哪些？市場的主要挑戰和商業風險是什麼？
  • Q.5.這個市場的商業風險和競爭威脅為何？
  • Q.6.這個市場有哪些新趨勢？理由為何？
  • Q.7.市場客戶需求有何改變？
  • Q.8.該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10.該市場上的競爭產品有哪些？由於材料或產品替代而導致市場佔有率下降的威脅有多大？
  • Q.11.過去年度發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章 執行摘要

第2章 全球假性腸阻塞治療市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球假性腸阻塞治療市場趨勢（2018-2023）與預測（2024-2030）
  • 按症狀分類的全球假性腸阻塞治療市場
    • 急性
    • 慢性的
  • 全球假性腸阻塞治療市場，依診斷
    • 體檢
    • 切片檢查
    • 驗血
    • 排放試驗
    • 影像檢查
    • 其他
  • 按治療方式分類的全球假性腸阻塞治療市場
    • 藥品
    • 外科手術
    • 飲食
    • 其他
  • 全球假性腸阻塞治療市場，依最終用途
    • 醫院和診所
    • 門診治療中心
    • 其他

第4章 2018-2030年市場趨勢及預測分析，依地區

  • 全球假性腸阻塞治療市場，依區域
  • 北美假性腸阻塞治療市場
  • 歐洲假性腸阻塞治療市場
  • 亞太地區假性腸阻塞治療市場
  • 其他區域性假性腸阻塞治療市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球假性腸阻塞治療市場成長機會，按症狀
    • 全球假性腸阻塞治療市場成長機會，按診斷
    • 全球假性腸阻塞治療市場成長機會，依治療方式
    • 全球假性腸阻塞治療市場成長機會，依最終用途
    • 全球假性腸阻塞治療市場成長機會，依地區
  • 全球假性腸阻塞治療市場新趨勢
  • 戰略分析
    • 新產品開發
    • 全球假性腸阻塞治療市場的產能擴張
    • 全球假性腸阻塞治療市場的合併、收購與合資企業
    • 認證和許可

第7章 主要企業概況

  • Pfizer
  • Cipla
  • GlaxoSmithKline
  • Teva Pharmaceutical
  • Eli Lilly
  • Novartis
  • Johnson & Johnson
  • Dr. Reddy's Laboratories
  • F. Hoffmann-La Roche
  • Lupin Limited
簡介目錄

Intestinal Pseudo Obstruction Treatment Trends and Forecast

The future of the global intestinal pseudo obstruction treatment market looks promising with opportunities in the hospitals & clinic and ambulatory care center markets. The global intestinal pseudo obstruction treatment market is expected to reach an estimated $21.40 billion by 2030 with a CAGR of 5.1% from 2024 to 2030. The major drivers for this market are increasing prevalence of gastrointestinal cases, rising awareness among healthcare providers and patients, and growing pharmaceutical innovations for specific treatments.

A more than 150-page report is developed to help in your business decisions.

Intestinal Pseudo Obstruction Treatment by Segment

The study includes a forecast for the global intestinal pseudo obstruction treatment by condition, diagnosis, treatment, end use, and region.

Intestinal Pseudo Obstruction Treatment Market by Condition [Shipment Analysis by Value from 2018 to 2030]:

  • Acute
  • Chronic

Intestinal Pseudo Obstruction Treatment Market by Diagnosis [Shipment Analysis by Value from 2018 to 2030]:

  • Physical Examination
  • Biopsy
  • Blood Test
  • Gastric Emptying Tests
  • Imaging Tests
  • Others

Intestinal Pseudo Obstruction Treatment Market by Treatment [Shipment Analysis by Value from 2018 to 2030]:

  • Medication
  • Surgery
  • Diet
  • Others

Intestinal Pseudo Obstruction Treatment Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals & Clinics
  • Ambulatory Care Centers
  • Others

Intestinal Pseudo Obstruction Treatment Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Intestinal Pseudo Obstruction Treatment Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies intestinal pseudo obstruction treatment companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the intestinal pseudo obstruction treatment companies profiled in this report include-

  • Pfizer
  • Cipla
  • Glaxosmithkline
  • Teva Pharmaceutical
  • Eli Lilly
  • Novartis
  • Johnson & Johnson
  • Dr. Reddy'S Laboratories
  • F. Hoffmann-La Roche
  • Lupin Limited

Intestinal Pseudo Obstruction Treatment Market Insights

  • Lucintel forecasts that medication will remain the largest segment over the forecast period.
  • Hospitals will remain the largest segment due to as hospital playa an important role in the treatment of intestinal pseudo-obstruction, especially in managing severe cases and complications.
  • North America will remain the largest segment over the forecast period due to increasing awareness towards diseases, presence of major players, and expanding healthcare industry in the region.

Features of the Global Intestinal Pseudo Obstruction Treatment Market

  • Market Size Estimates: Intestinal pseudo obstruction teatment market size estimation in terms of value ($B).
  • Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
  • Segmentation Analysis: Intestinal pseudo obstruction teatment market by various segments, such as by condition, diagnosis, treatment, end use and region in terms of($B).
  • Regional Analysis: Intestinal pseudo obstruction teatment market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different conditions, diagnosis, treatment, end uses, and region.s for the intestinal pseudo obstruction treatment market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the intestinal pseudo obstruction treatment market.
  • Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the intestinal pseudo obstruction treatment market size?

Answer: The global intestinal pseudo obstruction treatment market is expected to reach an estimated $21.40 billion by 2030.

Q.2. What is the growth forecast for intestinal pseudo obstruction treatment market?

Answer: The global intestinal pseudo obstruction treatment market is expected to grow with a CAGR of 5.1% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the intestinal pseudo obstruction treatment market?

Answer: The major drivers for this market are increasing prevalence of gastrointestinal cases, rising awareness among healthcare providers and patients, and growing pharmaceutical innovations for specific treatments.

Q.4. What are the major segments for intestinal pseudo obstruction treatment market?

Answer: The future of the intestinal pseudo obstruction treatment market looks promising with opportunities in the hospitals & clinic and ambulatory care center markets.

Q.5. Who are the key intestinal pseudo obstruction treatment market companies?

Answer: Some of the key intestinal pseudo obstruction treatment companies are as follows:

  • Pfizer
  • Cipla
  • GlaxoSmithKline
  • Teva Pharmaceutical
  • Eli Lilly
  • Novartis
  • Johnson & Johnson
  • Dr. Reddy's Laboratories
  • F. Hoffmann-La Roche
  • Lupin Limited

Q.6. Which intestinal pseudo obstruction treatment market segment will be the largest in future?

Answer: Lucintel forecasts that medication will remain the largest segment over the forecast period.

Q.7. In intestinal pseudo obstruction treatment market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest segment over the forecast period due to increasing awareness towards diseases, presence of major players, and expanding healthcare industry in the region.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the intestinal pseudo obstruction treatment market by condition (acute and chronic), diagnosis (physical examination, biopsy, blood test, gastric emptying tests, imaging tests, and others), treatment (medication, surgery, diet, and others), end use (hospitals & clinics, ambulatory care centers, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Intestinal Pseudo Obstruction Treatment Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Intestinal Pseudo Obstruction Treatment Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Intestinal Pseudo Obstruction Treatment Market by Condition
    • 3.3.1: Acute
    • 3.3.2: Chronic
  • 3.4: Global Intestinal Pseudo Obstruction Treatment Market by Diagnosis
    • 3.4.1: Physical Examination
    • 3.4.2: Biopsy
    • 3.4.3: Blood Test
    • 3.4.4: Gastric Emptying Tests
    • 3.4.5: Imaging Tests
    • 3.4.6: Others
  • 3.5: Global Intestinal Pseudo Obstruction Treatment Market by Treatment
    • 3.5.1: Medication
    • 3.5.2: Surgery
    • 3.5.3: Diet
    • 3.5.4: Others
  • 3.6: Global Intestinal Pseudo Obstruction Treatment Market by End Use
    • 3.6.1: Hospitals & Clinics
    • 3.6.2: Ambulatory Care Centers
    • 3.6.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Intestinal Pseudo Obstruction Treatment Market by Region
  • 4.2: North American Intestinal Pseudo Obstruction Treatment Market
    • 4.2.2: North American Intestinal Pseudo Obstruction Treatment Market by End Use: Hospitals & Clinics, Ambulatory Care Centers, and Others
  • 4.3: European Intestinal Pseudo Obstruction Treatment Market
    • 4.3.1: European Intestinal Pseudo Obstruction Treatment Market by Treatment: Medication, Surgery, Diet, and Others
    • 4.3.2: European Intestinal Pseudo Obstruction Treatment Market by End Use: Hospitals & Clinics, Ambulatory Care Centers, and Others
  • 4.4: APAC Intestinal Pseudo Obstruction Treatment Market
    • 4.4.1: APAC Intestinal Pseudo Obstruction Treatment Market by Treatment: Medication, Surgery, Diet, and Others
    • 4.4.2: APAC Intestinal Pseudo Obstruction Treatment Market by End Use: Hospitals & Clinics, Ambulatory Care Centers, and Others
  • 4.5: ROW Intestinal Pseudo Obstruction Treatment Market
    • 4.5.1: ROW Intestinal Pseudo Obstruction Treatment Market by Treatment: Medication, Surgery, Diet, and Others
    • 4.5.2: ROW Intestinal Pseudo Obstruction Treatment Market by End Use: Hospitals & Clinics, Ambulatory Care Centers, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Intestinal Pseudo Obstruction Treatment Market by Condition
    • 6.1.2: Growth Opportunities for the Global Intestinal Pseudo Obstruction Treatment Market by Diagnosis
    • 6.1.3: Growth Opportunities for the Global Intestinal Pseudo Obstruction Treatment Market by Treatment
    • 6.1.4: Growth Opportunities for the Global Intestinal Pseudo Obstruction Treatment Market by End Use
    • 6.1.5: Growth Opportunities for the Global Intestinal Pseudo Obstruction Treatment Market by Region
  • 6.2: Emerging Trends in the Global Intestinal Pseudo Obstruction Treatment Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Intestinal Pseudo Obstruction Treatment Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Intestinal Pseudo Obstruction Treatment Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Pfizer
  • 7.2: Cipla
  • 7.3: GlaxoSmithKline
  • 7.4: Teva Pharmaceutical
  • 7.5: Eli Lilly
  • 7.6: Novartis
  • 7.7: Johnson & Johnson
  • 7.8: Dr. Reddy's Laboratories
  • 7.9: F. Hoffmann-La Roche
  • 7.10: Lupin Limited